BioSpace News Archive

Drug Development

Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19Activities Proceeding for Phase 2/3 Trial Examining the Effects of Tempol for the Treatment of COVID-19

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that clinical trial start-up activities are underway for examining the effects of Tempol.

June 11, 2021
·
6 min read
Business

Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

Humacyte, Inc. announces the expansion of the strategic collaboration between Fresenius Medical Care.

June 11, 2021
·
11 min read
Lone Star Bio

SWK Holdings’ Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics

SWK Holdings Corporation today announced that its wholly-owned subsidiary, Enteris BioPharma, received a $10 million milestone payment from Cara Therapeutics.

June 11, 2021
·
5 min read
Business

Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer

Invitae today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 2021.

June 11, 2021
·
3 min read
BioCapital

Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis

Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for ruxolitinib cream for the treatment of atopic dermatitis (AD).

June 11, 2021
·
3 min read
Pharm Country

Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences - June 11, 2021

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced that members of its leadership team will present at the following virtual investor conferences in June and July

June 11, 2021
·
2 min read
Drug Development

Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting

Scholar Rock today announced an oral presentation of TOPAZ Phase 2 trial results by the lead principal investigator, Thomas Crawford, M.D. of Johns Hopkins Medicine, at the Cure SMA Annual SMA Conference.

June 11, 2021
·
11 min read
Aptose Presents Highlights from EHA During Corporate Update Event

Aptose Biosciences Inc. is releasing highlights from a corporate update event being held today, Friday, June 11, 2021, at 8:00 a.m. ET.

June 11, 2021
·
8 min read
Pharvaris Announces Annual Meeting of Shareholders

Pharvaris today announced the annual general meeting of shareholders will take place on Tuesday, June 29, 2021 at 1:00 p.m. CEST (7:00 a.m. EDT).

June 11, 2021
·
1 min read
Business

BeyondSpring to Host First Quarter Financial Results and Corporate Update Conference Call on June 16, 2021

BeyondSpring Inc. today announced that management will host a conference call to report its financial results for the first quarter ended March 31, 2021 and provide an update on recent corporate events on June 16, 2021 at 8:30 AM Eastern Time.

June 11, 2021
·
1 min read